PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation — Stella

Home/Atrial Fibrillation/

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation trials

Trial locations(1 site)

France

Institut Coeur-Poumon, CHU, Lille

Key details

Sponsor

University Hospital, Lille

Enrollment target

~750 participants

Started

February 2023

Primary completion

February 2031

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.